Company Overview - TriSalus Life Sciences is a mission-driven company focused on enhancing drug delivery to pancreatic, liver, and solid tumors [3] - The company is developing nelitolimod, an immunotherapeutic aimed at reversing immunosuppression in tumors, with the goal of improving patient outcomes for those suffering from serious cancers [3] Event Highlights - The inaugural webinar features discussions on uterine fibroids embolization, presented by distinguished physicians Dr. Nicole Lamparello and Dr. Francis Kang, highlighting it as a preferable alternative to surgery for patients with uterine fibroids [2] - The event aims to illustrate the value of TriSalus's technology in addressing significant medical challenges [2]

Table of Contents As filed with the U.S. Securities and Exchange Commission on December 14, 2023. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TRISALUS LIFE SCIENCES, INC. (Exact name of registrant as specified in its charter) 3841 (Primary Standard Industrial Mary Szela Chief Executive Officer 6272 W. 91st Ave. Westminster, Colorado 80031 (888) 321-5212 (Name, address, including zip code, and tele ...